|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4096 USD | +2.53% |
|
+8.94% | -65.14% |
| 06-12 | BioRestorative Therapies, Inc. Announces Board and Committee Changes | CI |
| 06-12 | BioRestorative Therapies, Inc. Enters Into $1,000,000 Revolving Loan Agreement With Bowery Group LLC | CI |
Company Valuation: BioRestorative Therapies, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 15.16 | 10.1 | 8.19 | 9.895 | 10.43 | 10.44 | - | - |
| Change | - | -33.36% | -18.94% | 20.83% | 5.4% | 0.06% | - | - |
| Enterprise Value (EV) | 15.16 | 10.1 | 8.19 | 9.895 | 10.43 | 10.44 | 10.44 | 10.44 |
| Change | - | -33.36% | -18.94% | 20.83% | 5.4% | 0.06% | 0% | 0% |
| P/E | -0.12x | -0.54x | -0.51x | -1.23x | -0.74x | -0.81x | -0.99x | -0.98x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | -0x | 0x | 0.1x | -0.79x |
| Capitalization / Revenue | 330x | 84.3x | 56.2x | 24.7x | 29x | 7.43x | 4.51x | 3.34x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 7.43x | 4.51x | 3.34x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.77x | -0.67x | -0.58x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -37.3 | -5.11 | -3.42 | -1.16 | -1.58 | -0.495 | -0.405 | -0.41 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.046 | 0.1198 | 0.1458 | 0.401 | 0.3597 | 1.405 | 2.312 | 3.125 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -26.31 | -18.97 | -15.22 | -11.56 | -15.65 | -13.61 | -15.67 | -17.97 |
| Net income 1 | -44.3 | -18.49 | -14.42 | -8.979 | -14.24 | -13.52 | -15.56 | -17.83 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 4.3400 | 2.7500 | 1.7399 | 1.4300 | 1.1750 | 0.4007 | 0.4007 | 0.4007 |
| Nbr of stocks (in thousands) | 3,493 | 3,674 | 4,707 | 6,920 | 8,876 | 25,478 | - | - |
| Announcement Date | 3/30/22 | 3/27/23 | 4/1/24 | 3/28/25 | 3/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.81x | - | - | - | 10.18M | |
| 33.03x | 8.6x | 25.99x | 0.06% | 56.24B | |
| 16.44x | 4.92x | 10.69x | 1.83% | 43.76B | |
| -18.06x | 4.28x | -7.47x | -.--% | 23.32B | |
| -37.29x | 12.3x | -35.89x | -.--% | 21.34B | |
| 19.43x | 3.77x | 9.8x | -.--% | 15.75B | |
| 21.69x | 4.34x | 14.37x | -.--% | 15.6B | |
| 16.58x | 4.78x | 11.21x | -.--% | 13.18B | |
| -421.16x | 28.6x | -3188.16x | -.--% | 12.01B | |
| 39.27x | 15.14x | 44.47x | -.--% | 11.87B | |
| Average | -33.09x | 9.64x | -346.11x | 0.21% | 21.31B | |
| Weighted average by Cap. | -11.11x | 8.33x | -170.04x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BRTX Stock
- Valuation BioRestorative Therapies, Inc.
Select your edition
All financial news and data tailored to specific country editions
